BiotechTube
Home/GeneCentric Therapeutics/Michael V. Milburn, PhD
MV

Michael V. Milburn, PhD

Chief Executive Officer and President

GeneCentric Therapeutics

Therapeutic Areas

Oncology

GeneCentric Therapeutics Pipeline

DrugIndicationPhase
PurIST®Pancreatic Ductal Adenocarcinoma (PDAC)Commercial
GenomicsNext™ PlatformOncology (Multiple Tumor Types)Development/Discovery

Leadership Team at GeneCentric Therapeutics

KB
Kirk Beebe, PhD
Chief Scientific Officer
View full GeneCentric Therapeutics profile